XERS ▲ +9.2% - Xeris Biopharma Holdings, Inc.
$XERS reported Q3 2026 Adj EPS of $0.06, beating the $0.03 estimate by 100.0%. Revenue of $106.3M beat the $101.5M estimate by 4.7%.
05-NOV-2026 07:14 AM ET
Share this post
More filings for $XERS
XERS - Xeris Biopharma Holdings, Inc. - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 30, 2026XERS ▲ +0.2% - Xeris Biopharma Holdings, Inc.Oct 6, 2026XERS ▼ -0.4% - Xeris Biopharma Holdings, Inc.Oct 6, 2026XERS ▼ -0.6% - Xeris Biopharma Holdings, Inc.Sep 9, 2026$XERS SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $XERS filing history →💬 Comments
Loading comments…
Leave a comment